Preview

Kuban Scientific Medical Bulletin

Advanced search

CLINICAL ANALYSIS OF EFFICACY OF ELECTROCONVULSIVE THERAPY WITH MODERN ANESTHETIC SUPPORT IN PSYCHIATRIC PRACTICE

https://doi.org/10.25207/1608-6228-2017-24-6-35-41

Abstract

Aim. Clinical analysis of the efficacy of electroconvulsive therapy (ECT) in conditions of intensive care units (ICU) in psychiatric dispensary. Materials and methods. Within the two years of ICU functioning 150 patients (73 men and 77 women) aged 17 to 66 were treated with ECT in the Aksai branch of the "Psychoneurological Dispensary". For the course of therapy, the number of ECT sessions was from 2 to 24. The sessions were conducted both daily and at a frequency of 1-3 times a week, depending on the nosology. To assess the efficacy of ECT, a clinical global impression scale (CGI-I) was used. Results. A significant improvement in the state (1-2 on the CGI-I scale) after ECT sessions was observed in 108 patients (72%), slight improvement in 30 patients (20%), absence of changes in 9 patients (6%) and deterioration in 3 patients (2 %). High clinical efficacy of ECT prevailed in the spectrum of patient changes in the clinical group. Regardless the leading syndrome, a significant improvement in the state after the use of ECT prevailed in frequency. Taking into account the diagnostic category and the syndrome, the best effect was observed in the catatonic-oneiroid syndrome in paroxysmal (recurrent) schizophrenia, malignant neuroleptic syndrome, affective-delusional syndrome in schizoaffective disorder, catatonic paranoid and paranoid syndromes within the paranoid schizophrenia with episodic-progressive type of course with an increasing defect, as well as in paranoid schizophrenia with a follow-up period of up to 1 year. ECT was effective in overcoming psychopharmacotherapeutic resistance. Conclusion. Use of ECT in the "modified" version is a highly effective method of biological therapy, providing therapeutic results in catatonic paroxysmal (recurrent) schizophrenia, schizoaffective disorder, paranoid paroxysmal schizophrenia, paranoid schizophrenia with a follow-up period of up to 1 year, as well as in the treatment of malignant neuroleptic syndrome and psychopharmacotherapy resistant conditions.

 

About the Authors

I. V. DUBATOVA
Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation


S. A. SOLOV'EVA
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


I. N. KUCHERENKO
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


N. V. NIKONOVA
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


I. V. STOJAKIN
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


K. A. KARNAUH
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


O. A. TREPKO
Aksay Branch "Psychoneurological Dispensary"
Russian Federation


A. V. SAFRONENKO
Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation


References

1. Нельсон А.И. Электросудорожная терапия в психиатрии, наркологии и неврологии. М.: БИНОМ. Лаборатория знаний, 2005. 368 с. [Nelson A.I. Jelektrosudorozhnaja terapija v psihiatrii, narkologii i nevrologii. Moscow: BINOM. Laboratory of Knowledge, 2005. 368 p. (In Russ.)].

2. Иванов М.В., Зубов Д.С. Патогенетические аспекты электросудорожной терапии: гипотезы и доказательства. Российский психиатрический журнал. 2014; 1: 57-61. [Ivanov M.V., Zubov D.S. Pathogenetic aspects of electroconvulsive therapy: hypotheses and evidence. Russian Psychiatric Journal. 2014; 1: 57-61. (In Russ., English abstract)].

3. Иванов М.В., Петрова Н.Н., Королева А.Е., Чомская В.М., Калева М.А. Электросудорожная терапия: история и современная практика. Психиатрия и психофармакотерапия. 2013; 3(15): 18-23. [Ivanov M.V., Petrova N.N., Koroleva A.E., Chomskaya V.M., Kaleva M.A. Electrosus-road therapy: history and modern practice. Psychiatry and psychopharmacotherapy. 2013; 3(15): 18- 23. (In Russ., English abstract)].

4. Youn T., Kang U.G., Kim Y.S., Chung I.W. Recent Trends for Optimization of Electroconvulsive Therapy. J. Korean Neuropsychiatr. Assoc. 2016 Feb; 55(1): 12-24.

5. Григорян А.З. Эффективность терапии аффективных нарушений у пациентов, страдающих аддиктивной патологией, методом электросудорожной терапии. Психиатрия, психотерапия и клиническая психология. 2015; 4(22): 143-151. [Grigoryan A.Z. Efficiency of therapy of affective disorders in patients suffering from addictive pathology, using electroconvulsive therapy. Psychiatry, psychotherapy and clinical psychology. 2015; 4(22): 143-151. (In Russ., English abstract)].

6. Сизов С.В. Подходы к терапии шизофрении с применением электросудорожной терапии. Бюллетень медицинских интернет-конференций. 2016; 6(6): 1119. [Sizov S.V. Approaches to the therapy of schizophrenia with the use of electroconvulsive therapy. Bulletin of medical Internet conferences. 2016; 6(6): 1119. (In Russ., English abstract)].

7. Сизов С.В., Барыльник Ю.Б., Воронцов О.В., Деева М.А. Электросудорожная терапия в Саратовской области: современная практика. Бюллетень медицинских интернет-конференций. 2015; 2(5): 111. [Sizov S.V., Barylnik Yu.B., Vorontsov O.V., Deeva M.A. Electroconvulsive therapy in the Saratov region: modern practice. Bulletin of medical Internet conferences. 2015; 2(5): 111. (In Russ., English abstract)].

8. Perrin J.S., Merz, S., Bennett, D.M. Electroconvulsive therapy reduces frontal connectivity in severe depressive disorder. Proceedings of the National Academy of Sciences. 2012; 109: 5464-5468.

9. Малин Д.И., Равилов Р.С. Распространенность, клиника, диагностика и терапия тяжелых осложнений нейролептической терапии. Социальная и клиническая медицина. 2014; 4(24): 90-96. [Malin D.I., Ravilov R.S. Prevalence, clinic, diagnosis and therapy of severe complications of neuroleptic therapy. Social and clinical medicine. 2014; 4(24): 90-96. (In Russ., English abstract)].

10. Петрова Н.Н., Иванов М.В., Калева М.А., Чомская В.М. Эффективность сочетанной электросудорожной и нейролептической терапии в преодолении терапевтической резистентности у больных шизофренией. Фарматека. 2013; 3: 59-63. [Petrova N.N., Ivanov M.V., Kaleva M.A., Chomskaya V.М. Efficiency of combined electroconvulsive and neuroleptic therapy in overcoming therapeutic resistance in patients with schizophrenia. Pharmateka. 2013; 3: 59-63. (In Russ., English abstract)].

11. Петрова Н.Н., Иванов М.В., Зубов Д.С., Калева М.А., Чомская В.М. Показатели переносимости и безопасности сочетанного применения электросудорожной терапии и антипсихотиков (второй генерации) при стационарном лечении обострений шизофрении. Вестник Санкт-Петербургского университета. Серия 11. Медицина. 2014; 2: 44-53. [Petrova N.N., Ivanov M.V., Zubov D.S., Kaleva M.A., Chomskaya V.М. Indices of the transferability and safety of the combined use of electroconvulsive therapy and antipsychotics (second generation) in the hospital treatment of exacerbations of schizophrenia. [Bulletin of the St. Petersburg University. Series 11.Medicine. 2014; 2: 44-53. (In Russ., English abstract)].

12. Малин Д.И., Костицын Н.В. Клиника и терапия эндогенных психозов, осложненных злокачественным нейролептиче- ским синдромом. М.: Спутник, 1996. 166 c. [Malin D.I., Kostitsyn N.V. Klinika i terapija jendogennyh psihozov, oslozhnennyh zlokachestvennym nejrolepticheskim sindromom. Moscow: Sputnik, 1996. 166 р. (In Russ.)].

13. Авруцкий Г.Я., Недува А.А. Лечение психически больных. М.: Медицина, 1988. 528 с. [Avrutsky G.Y., Neduva A.A. Lechenie psihicheski bol'nyh. M.: Medicine, 1988. 528 p. (In Russ.)].


Review

For citations:


DUBATOVA I.V., SOLOV'EVA S.A., KUCHERENKO I.N., NIKONOVA N.V., STOJAKIN I.V., KARNAUH K.A., TREPKO O.A., SAFRONENKO A.V. CLINICAL ANALYSIS OF EFFICACY OF ELECTROCONVULSIVE THERAPY WITH MODERN ANESTHETIC SUPPORT IN PSYCHIATRIC PRACTICE. Kuban Scientific Medical Bulletin. 2017;(6):35-41. (In Russ.) https://doi.org/10.25207/1608-6228-2017-24-6-35-41

Views: 468


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1608-6228 (Print)
ISSN 2541-9544 (Online)